Mon - Fri 8:00 - 6:30

Because everything affects our health, life, and legacy.

News & Your Opinion

News & Your Opinion

FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients

On HALO

5 months ago

Ozempic, the drug that was originally approved to treat type 2 diabetes, has now also been approved by the FDA to reduce certain risks associated with chronic kidney disease.

HALO NEWSLETTER

Join HALO today and unlock this story instantly — It's Free

5 months ago
On HALO

Opinion and Comments